Joanne E. Davis

1.5k total citations
36 papers, 1.2k citations indexed

About

Joanne E. Davis is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Joanne E. Davis has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 15 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Joanne E. Davis's work include Immune Cell Function and Interaction (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Joanne E. Davis is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Joanne E. Davis collaborates with scholars based in Australia, United States and China. Joanne E. Davis's co-authors include Joseph A. Trapani, Vivien R. Sutton, Mark J. Smyth, Kylie A. Browne, Ricky W. Johnstone, Astrid A. Ruefli, Michael Cancilla, Karin Sedelies, Michael G. Milgroom and Denis J. Moss and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Joanne E. Davis

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne E. Davis Australia 17 527 408 307 225 142 36 1.2k
Fazel Shokri Iran 21 611 1.2× 406 1.0× 218 0.7× 145 0.6× 41 0.3× 74 1.2k
Pieter Spee Denmark 20 1.4k 2.7× 557 1.4× 424 1.4× 183 0.8× 30 0.2× 32 1.9k
Peter Sobieszczuk France 14 505 1.0× 559 1.4× 187 0.6× 216 1.0× 24 0.2× 15 1.2k
Tamara C. Pozos United States 8 352 0.7× 222 0.5× 82 0.3× 238 1.1× 47 0.3× 17 812
Lorea Manterola Spain 21 182 0.3× 1.2k 2.9× 230 0.7× 174 0.8× 51 0.4× 27 1.8k
Fuping Zhang China 15 849 1.6× 290 0.7× 173 0.6× 185 0.8× 50 0.4× 32 1.3k
Monique Gannagé Switzerland 21 700 1.3× 397 1.0× 235 0.8× 776 3.4× 24 0.2× 30 1.5k
Florentina Marches United States 17 1.0k 2.0× 378 0.9× 559 1.8× 149 0.7× 96 0.7× 29 1.8k
Sherry Mou United States 14 400 0.8× 350 0.9× 162 0.5× 61 0.3× 29 0.2× 28 860
Élisabeth Devilard France 20 1.3k 2.6× 588 1.4× 352 1.1× 199 0.9× 13 0.1× 28 2.1k

Countries citing papers authored by Joanne E. Davis

Since Specialization
Citations

This map shows the geographic impact of Joanne E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne E. Davis more than expected).

Fields of papers citing papers by Joanne E. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne E. Davis. The network helps show where Joanne E. Davis may publish in the future.

Co-authorship network of co-authors of Joanne E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne E. Davis. A scholar is included among the top collaborators of Joanne E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne E. Davis. Joanne E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, Joanne E., Mandy Ludford‐Menting, Rachel Koldej, & David Ritchie. (2024). Modified cell trace violet proliferation assay preserves lymphocyte viability and allows spectral flow cytometry analysis. Cytometry Part A. 105(5). 394–403. 2 indexed citations
2.
Davis, Joanne E., Mandy Ludford‐Menting, Sasanka M. Handunnetti, et al.. (2024). Marginal Zone Lymphoma Is Associated with Dysregulated Peripheral Blood Immunity Which Is Not Changed By Ibrutinib-Venetoclax Treatment. Blood. 144(Supplement 1). 4384–4384.
3.
Shortt, Jake, Peter Galettis, Chan Y. Cheah, et al.. (2023). A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma. Clinical Epigenetics. 15(1). 15–15. 3 indexed citations
4.
Davis, Joanne E., et al.. (2021). Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence. Journal of Translational Medicine. 19(1). 473–473. 17 indexed citations
5.
Davis, Joanne E., Kylie D. Mason, Dale I. Godfrey, et al.. (2018). More Than a BTK Inhibitor; Ibrutinib Profoundly Impacts the Function of Cell Mediated Immunity. Blood. 132(Supplement 1). 4417–4417. 1 indexed citations
6.
Davis, Joanne E., et al.. (2018). Comparison of gene expression and flow cytometry for immune profiling in chronic lymphocytic leukaemia. Journal of Immunological Methods. 463. 97–104. 5 indexed citations
7.
Wong, Eric, et al.. (2018). Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation. 54(2). 175–189. 7 indexed citations
8.
Jiao, Yuhao, Joanne E. Davis, Jai Rautela, et al.. (2018). Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes. Cell Death and Differentiation. 26(8). 1516–1530. 10 indexed citations
9.
Neeson, Paul J., Andy Hsu, Heloise M. Halse, et al.. (2015). Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib. OncoImmunology. 4(9). e1038011–e1038011. 5 indexed citations
10.
Davis, Joanne E., Michael Harvey, Nicholas A. Gherardin, et al.. (2014). A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in Mice. Biology of Blood and Marrow Transplantation. 21(2). 242–249. 2 indexed citations
11.
Lutzky, Viviana P., Pauline Crooks, Natasha Stevens, et al.. (2013). Cytotoxic T Cell Adoptive Immunotherapy as a Treatment for Nasopharyngeal Carcinoma. Clinical and Vaccine Immunology. 21(2). 256–259. 30 indexed citations
13.
Davis, Joanne E.. (2004). Determining virological, serological and immunological parameters of EBV infection in the development of PTLD. International Immunology. 16(7). 983–989. 28 indexed citations
14.
Davis, Joanne E. & Denis J. Moss. (2004). Treatment options for post‐transplant lymphoproliferative disorder and other Epstein–Barr virus‐associated malignancies. Tissue Antigens. 63(4). 285–292. 24 indexed citations
15.
Sherritt, Martina A., Mandvi Bharadwaj, Jacqueline M. Burrows, et al.. (2003). Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation. 75(9). 1556–1560. 74 indexed citations
16.
Davis, Joanne E., Vivien R. Sutton, Kylie A. Browne, & Joseph A. Trapani. (2003). Purification of natural killer cell cytotoxic granules for assaying target cell apoptosis. Journal of Immunological Methods. 276(1-2). 59–68. 18 indexed citations
17.
Trapani, Joseph A., Joanne E. Davis, Vivien R. Sutton, & Mark J. Smyth. (2000). Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Current Opinion in Immunology. 12(3). 323–329. 112 indexed citations
18.
Davis, Joanne E., Vivien R. Sutton, Mark J. Smyth, & Joseph A. Trapani. (2000). Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1. Cell Death and Differentiation. 7(10). 973–983. 46 indexed citations
19.
Yu, Xue‐Zhong, Lei Zhu, Joanne E. Davis, et al.. (1996). Induction of apoptosis by anti-CD3 epsilon F(ab')2 in antigen receptor transgenic murine T cells activated by specific peptide. The Journal of Immunology. 157(8). 3420–3429. 17 indexed citations
20.
Gallagher, Grant, et al.. (1989). Cytokines regulate the ability of human LAK-cells to kill human tumour cells in vitro. British Journal of Cancer. 59(6). 919–921. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026